So, TT really it’s probably only an FDA approval that will move...

So, TT really it’s probably only an FDA approval that will move the dial on the share price. Most likely all other so called milestone announcements will be largely ignored by the market.

So, with zero FDA approved trials why is this company confident of obtaining FDA approval on anything? Bile duct? C’mon that’s been mentioned for over 5 years. With nothing to show for it.

This so called European expansion has resulted in 5 sales approx per quarter. It’s a dismal failure as far as generating any meaningful commercial sales. The company itself has even recognised this very fact in its latest prospectus saying it’s struggling to generate any significant commercial sales as a risk factor.

The company has never provided a forecast for commercial sales has it? There’s a vote of confidence in its abilities!

For whatever reason, the company has been unable to secure GBA approval even though it was touted over 2 years ago now.